Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture

Human Reproduction
V BracheHoracio B Croxatto

Abstract

Current methods of hormonal emergency contraception (EC) are ineffective in preventing follicular rupture when administered in the advanced pre-ovulatory phase. This study was designed to determine the capacity of ulipristal acetate (UPA), a selective progesterone receptor modulator developed for EC, to block follicular rupture when administered with a follicle of >or=18 mm. This was a double-blind, crossover, randomized, placebo-controlled study. Thirty-five women contributed with UPA (30 mg. oral) and a placebo cycle. Serial blood sampling for luteinizing hormone (LH), estradiol and progesterone measurements and follicular monitoring by ultrasound were performed before and for 5 days following treatment. Follicular rupture inhibition was assessed in the overall study population and in subgroups of women stratified by when treatment was administered in relation to LH levels (before the onset of the LH surge, after the onset of the surge but before the LH peak or after the LH peak). Follicular rupture failed to occur for at least 5 days following UPA administration in 20/34 cycles [59%; 95% confidence interval (CI) (40.7-75.4%)], whereas rupture took place in all cycles within 5 days of placebo intake. When UPA was administered...Continue Reading

References

Jul 9, 2002·Obstetrics and Gynecology·Lena MarionsKristina Gemzell Danielsson
Jun 11, 2004·Human Reproduction·A J WilcoxClarice R Weinberg
Jun 12, 2004·Human Reproduction Update·K Gemzell-Danielsson, L Marions
Nov 2, 2006·Obstetrics and Gynecology·Mitchell D CreininJames Higgins
Jan 23, 2010·Obstetrics and Gynecology·Paul FineErin Gainer

❮ Previous
Next ❯

Citations

Dec 15, 2010·Advances in Therapy·Paul M Fine
Feb 7, 2013·Best Practice & Research. Clinical Endocrinology & Metabolism·P G L LalitkumarKristina Gemzell-Danielsson
Jun 16, 2012·Human Reproduction Update·UNKNOWN ESHRE Capri Workshop GroupAnna Glasier
Aug 13, 2011·Current Opinion in Obstetrics & Gynecology·Kaiyti Duffy, Melanie A Gold
Dec 6, 2011·International Journal of Women's Health·Ralph P Miech
May 17, 2011·Drugs·Kate McKeage, Jamie D Croxtall
May 10, 2012·Drugs·Jamie D Croxtall
Mar 16, 2013·Trends in Pharmacological Sciences·Bruno MozzanegaGiovanni Battista Nardelli
Feb 23, 2013·The Journal of Family Planning and Reproductive Health Care·Rebecca Jayne McKay, Lynne Gilbert
Oct 9, 2012·Contraception·Anna Glasier
Nov 2, 2012·Contraception·Kristina Gemzell-DanielssonLalitkumar P G L
Sep 27, 2012·Reproductive Sciences·Shanmugasundaram NallasamyIndrani Bagchi
May 3, 2014·Expert Opinion on Pharmacotherapy·Giuseppe BenagianoIvo Brosens
Nov 20, 2012·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·María José MunuceLuis Bahamondes
Jan 18, 2011·Expert Opinion on Emerging Drugs·Luis BahamondesIlza Monteiro
Mar 6, 2012·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Silvio TafuriRosa Prato
Jan 23, 2016·Frontiers in Pharmacology·Elena RosatoCarlo Bastianelli
Nov 20, 2015·Human Reproduction·Matías D Gómez-ElíasDébora J Cohen
Aug 21, 2012·Nursing for Women's Health·Jeanne M Wilton
Mar 15, 2012·Molecular and Cellular Endocrinology·Nathalie Chabbert-BuffetPhilippe Bouchard
Dec 14, 2011·Clinical Therapeutics·Ashley R Richardson, Fraidy N Maltz
Jan 7, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·David R Friend
Oct 12, 2010·Contraception·Kristina Gemzell-Danielsson
Sep 20, 2011·Pharmacotherapy·Sarah P ShraderSally Rafie
Oct 12, 2012·Journal of Midwifery & Women's Health·Patricia Aikins Murphy
Nov 26, 2015·Obstetrics and Gynecology Clinics of North America·Holly Bullock, Jennifer Salcedo
Jul 10, 2012·Contraception·Caroline Moreau, James Trussell
Aug 19, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Anna Glasier
Mar 6, 2013·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Kristina Gemzell-DanielssonLinan Cheng
Aug 15, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Kristina Gemzell-DanielssonP G Lalitkumar
Jul 10, 2012·Expert Opinion on Pharmacotherapy·Alan M Martinez, Michael A Thomas
Jun 6, 2014·Best Practice & Research. Clinical Obstetrics & Gynaecology·Hang-Wun Raymond LiPak-Chung Ho
Oct 22, 2014·Clinical Pharmacokinetics·Victoria TittleNneka Nwokolo
Oct 18, 2011·Gynécologie, obstétrique & fertilité·C JaminUNKNOWN Groupe de réflexion « oublis de pilule »
Nov 30, 2016·Archives of Gynecology and Obstetrics·Marion Kiechle, Miriam Neuenfeldt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.